We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+13.88%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$727M
AUM Growth
+$68.4M
Cap. Flow
-$9.77M
Cap. Flow %
-1.34%
Top 10 Hldgs %
27.48%
Holding
495
New
13
Increased
7
Reduced
15
Closed
11

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.31M
2
AMZN icon
Amazon
AMZN
+$1.07M
3
RPRX icon
Royalty Pharma
RPRX
+$660K
4
C icon
Citigroup
C
+$531K
5
SCHW
Charles Schwab
SCHW
+$508K

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$4.4M
2
AAPL icon
Apple
AAPL
+$2.23M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.2M
4
MSFT icon
Microsoft
MSFT
+$1.96M
5
LRCX icon
Lam Research
LRCX
+$1.02M

Sector Composition

Rank Sector Weight
1 Technology 27.37%
2 Healthcare 13.73%
3 Industrials 11.66%
4 Financials 11.66%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAGN
476
Magnera Corp
MAGN
$460M
$31K ﹤0.01%
1,231
– –
VERI icon
477
Veritone
VERI
$122M
$29K ﹤0.01%
16,000
– –
RDI icon
478
Reading International Class A
RDI
$34.3M
$25.8K ﹤0.01%
13,500
– –
PGEN icon
479
Precigen
PGEN
$2.59B
$20.1K ﹤0.01%
15,000
– –
SFE
480
DELISTED
Safeguard Scientifics, Inc.
SFE
$16.5K ﹤0.01%
21,000
– –
BBGI icon
481
Beasley Broadcasting Group
BBGI
$40M
$13.2K ﹤0.01%
750
– –
KYNB
482
Kyntra Bio
KYNB
$29.4M
$12.4K ﹤0.01%
560
– –
PVLA
483
Palvella Therapeutics
PVLA
$2.27B
$5.46K ﹤0.01%
375
– –
XXII
484
22nd Century Group
XXII
$1.48M
– –
0
– –
BHVN icon
485
Biohaven
BHVN
$2.21B
– –
-10,250
Closed -$267K
SIGI icon
486
Selective Insurance
SIGI
$5.73B
– –
-2,000
Closed -$206K
SNCR
487
DELISTED
Synchronoss Technologies
SNCR
– –
-6,000
Closed -$51.8K
INVX
488
Innovex International
INVX
$1.97B
– –
-8,000
Closed -$225K
VMW
489
DELISTED
VMware, Inc
VMW
– –
-1,598
Closed -$266K
NXGN
490
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
– –
-10,000
Closed -$237K
NEWR
491
DELISTED
New Relic, Inc.
NEWR
– –
-5,000
Closed -$428K
TRHC
492
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
– –
-10,000
Closed -$103K
HZNP
493
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-19,000
Closed -$2.2M
ATVI
494
DELISTED
Activision Blizzard
ATVI
– –
-47,000
Closed -$4.4M
EBIX
495
DELISTED
Ebix Inc
EBIX
– –
-11,000
Closed -$109K
16 17 18 19
20

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2023 Portfolio in Review

As of Q4 2023, NJ State Employees Deferred Compensation Plan held 495 positions worth $727M, up 10% from $658M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 4.8%. NJ State Employees Deferred Compensation Plan opened 13 new positions and exited 11, leaving the 495-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2023 buy was Royalty Pharma: 24,000 shares worth $674K.
  • NJ State Employees Deferred Compensation Plan added most to NVIDIA in Q4 2023, an estimated $4.31M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2023 reduction was Apple, cutting an estimated $2.23M.
  • NJ State Employees Deferred Compensation Plan fully exited Activision Blizzard in Q4 2023, selling an estimated $4.4M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 27% of its $727M portfolio in Q4 2023.
  • NJ State Employees Deferred Compensation Plan opened 13 new positions and closed 11 in Q4 2023.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 10% quarter-over-quarter to $727M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2023, filed 2 Feb 2024.